000 01624 a2200457 4500
005 20250513231555.0
264 0 _c20010315
008 200103s 0 0 eng d
022 _a0004-8666
024 7 _a10.1111/j.1479-828x.2000.tb01173.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMulvey, S F
245 0 0 _aThe utilisation of nuchal translucency as a prenatal marker of Down syndrome, 1993-1999.
_h[electronic resource]
260 _bThe Australian & New Zealand journal of obstetrics & gynaecology
_cNov 2000
300 _a423-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBiomarkers
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDown Syndrome
_xdiagnostic imaging
650 0 4 _aFemale
650 0 4 _aHealth Care Surveys
650 0 4 _aHumans
650 0 4 _aMass Screening
_xmethods
650 0 4 _aNeck
_xdiagnostic imaging
650 0 4 _aNeeds Assessment
650 0 4 _aPractice Patterns, Physicians'
_xeconomics
650 0 4 _aPregnancy
650 0 4 _aPregnancy Trimester, First
650 0 4 _aPrivate Practice
_xeconomics
650 0 4 _aReferral and Consultation
_xeconomics
650 0 4 _aReproducibility of Results
650 0 4 _aUltrasonography, Prenatal
_xeconomics
650 0 4 _aVictoria
700 1 _aAtchison, W G
700 1 _aGrimwade, J C
700 1 _aRenou, P M
700 1 _aShekleton, P A
700 1 _aWallace, E M
773 0 _tThe Australian & New Zealand journal of obstetrics & gynaecology
_gvol. 40
_gno. 4
_gp. 423-6
856 4 0 _uhttps://doi.org/10.1111/j.1479-828x.2000.tb01173.x
_zAvailable from publisher's website
999 _c11132609
_d11132609